← Back to all trials
Completed
NCT03949764
The Kentucky Viral Hepatitis Treatment Study
Conditions: Hepatitis C, Opioid-Related Disorders, Injection Drug Use
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: PHASE4
Enrollment: 380
Sponsor: Jennifer Havens
Location: ARH Medical Mall Hazard Kentucky
Summary
The overarching goal of the Kentucky Viral Hepatitis Treatment Project (KeY Treat) is to increase hepatitis C virus (HCV) treatment access and delivery in a rural Appalachian community, which is in the midst of the opioid/hepatitis C (HCV) syndemic. KeY Treat is a clinical research study seeking to determine whether removing barriers (cost, insurance, specialist, abstinence) associated with accessing direct-acting antivirals (DAAs) for the treatment of HCV will impact health in Perry County, Kentucky.
Eligibility Criteria
Inclusion Criteria:
* RNA positive for HCV
* Perry County residency (verified via ID card showing local address, lease, utility bill, etc.)
* 18 years of age or older
Exclusion Criteria:
* Individuals who are unable to provide consent (to be determined by local study staff in conjunction with our psychiatrist, Dr. Lofwall, a Co-I on the study)
* Individuals under 18 years of age (study drugs not FDA-approved for those \
Source: ClinicalTrials.gov (NCT03949764). StuddyBuddy aggregates publicly available trial information.
